Literature DB >> 23712688

Tropomyosin isoform expression and phosphorylation in the human heart in health and disease.

Steven B Marston1, O'Neal Copeland, Andrew E Messer, Elyshia MacNamara, Kristen Nowak, Cleidiane G Zampronio, Douglas G Ward.   

Abstract

We determined the isoforms of tropomyosin expressed and the level of tropomyosin phosphorylation in donor, end-stage failing and hypertrophic obstructive cardiomyopathy samples of human heart muscle. Western blots and isoform-specific antibodies showed that α-tropomyosin was the only significant isoform expressed and that tropomyosin was 25-30% phosphorylated at serine 283. Mass spectrometry confirmed directly that α-tropomyosin made up over 95% of tropomyosin but also indicated the presence of up to 4% κ-tropomyosin and much smaller amounts of β-, γ- and smooth β-tropomyosin and about 26% phosphorylation. Neither the isoform distribution nor the level of phosphorylation changed significantly in the pathological heart muscle samples.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23712688     DOI: 10.1007/s10974-013-9347-8

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  24 in total

1.  Regulatory proteins of the myocardium. Atrial and ventricular tropomyosin and troponin-I in the developing and adult bovine and human heart.

Authors:  J E Humphreys; P Cummins
Journal:  J Mol Cell Cardiol       Date:  1984-07       Impact factor: 5.000

2.  Tropomyosin dephosphorylation results in compensated cardiac hypertrophy.

Authors:  Emily M Schulz; Richard N Correll; Hajer N Sheikh; Marco S Lofrano-Alves; Patti L Engel; Gilbert Newman; Jo El J Schultz; Jeffery D Molkentin; Beata M Wolska; R John Solaro; David F Wieczorek
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

3.  The use of phosphate-affinity SDS-PAGE to measure the cardiac troponin I phosphorylation site distribution in human heart muscle.

Authors:  Andrew E Messer; Clare E Gallon; William J McKenna; Cristobal G Dos Remedios; Steven B Marston
Journal:  Proteomics Clin Appl       Date:  2009-10-13       Impact factor: 3.494

4.  Abnormal actin binding of aberrant β-tropomyosins is a molecular cause of muscle weakness in TPM2-related nemaline and cap myopathy.

Authors:  Minttu Marttila; Elina Lemola; William Wallefeld; Massimiliano Memo; Kati Donner; Nigel G Laing; Steven Marston; Mikaela Grönholm; Carina Wallgren-Pettersson
Journal:  Biochem J       Date:  2012-02-15       Impact factor: 3.857

5.  Tropomyosin 3 increases striated muscle isoform diversity.

Authors:  K Pieples; D F Wieczorek
Journal:  Biochemistry       Date:  2000-07-18       Impact factor: 3.162

6.  Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca(2+) activation.

Authors:  Kathy Pieples; Grace Arteaga; R John Solaro; Ingrid Grupp; John N Lorenz; Greg P Boivin; Ganapathy Jagatheesan; Erin Labitzke; Pieter P DeTombe; John P Konhilas; Thomas C Irving; David F Wieczorek
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06-13       Impact factor: 4.733

7.  Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy.

Authors:  P Anthony Akkari; Yuhua Song; Sarah Hitchcock-DeGregori; Lori Blechynden; Nigel Laing
Journal:  Biochem Biophys Res Commun       Date:  2002-08-16       Impact factor: 3.575

8.  Top-down targeted proteomics for deep sequencing of tropomyosin isoforms.

Authors:  Ying Peng; Xin Chen; Han Zhang; Qingge Xu; Timothy A Hacker; Ying Ge
Journal:  J Proteome Res       Date:  2012-12-20       Impact factor: 4.466

9.  Molecular and functional characterization of a novel cardiac-specific human tropomyosin isoform.

Authors:  Sudarsan Rajan; Ganapathy Jagatheesan; Chehade N Karam; Marco L Alves; Ilona Bodi; Arnold Schwartz; Christian F Bulcao; Karen M D'Souza; Shahab A Akhter; Greg P Boivin; Dipak K Dube; Natalia Petrashevskaya; Andrew B Herr; Roger Hullin; Stephen B Liggett; Beata M Wolska; R John Solaro; David F Wieczorek
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

10.  Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart.

Authors:  M Muthuchamy; I L Grupp; G Grupp; B A O'Toole; A B Kier; G P Boivin; J Neumann; D F Wieczorek
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

View more
  14 in total

Review 1.  Top-down mass spectrometry of cardiac myofilament proteins in health and disease.

Authors:  Ying Peng; Serife Ayaz-Guner; Deyang Yu; Ying Ge
Journal:  Proteomics Clin Appl       Date:  2014-08       Impact factor: 3.494

2.  MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.

Authors:  Thomas S O'Leary; Julia Snyder; Sakthivel Sadayappan; Sharlene M Day; Michael J Previs
Journal:  J Mol Cell Cardiol       Date:  2018-12-11       Impact factor: 5.000

3.  Identification, characterization, and expression of sarcomeric tropomyosin isoforms in zebrafish.

Authors:  Dipak K Dube; Syamalima Dube; Lynn Abbott; Jushuo Wang; Yingli Fan; Ruham Alshiekh-Nasany; Kalpesh K Shah; Alexander P Rudloff; Bernard J Poiesz; Jean M Sanger; Joseph W Sanger
Journal:  Cytoskeleton (Hoboken)       Date:  2017-01-24

4.  Distinct actin-tropomyosin cofilament populations drive the functional diversification of cytoskeletal myosin motor complexes.

Authors:  Theresia Reindl; Sven Giese; Johannes N Greve; Patrick Y Reinke; Igor Chizhov; Sharissa L Latham; Daniel P Mulvihill; Manuel H Taft; Dietmar J Manstein
Journal:  iScience       Date:  2022-05-30

5.  Comprehensive analysis of tropomyosin isoforms in skeletal muscles by top-down proteomics.

Authors:  Yutong Jin; Ying Peng; Ziqing Lin; Yi-Chen Chen; Liming Wei; Timothy A Hacker; Lars Larsson; Ying Ge
Journal:  J Muscle Res Cell Motil       Date:  2016-04-18       Impact factor: 2.698

6.  Qualitative and quantitative evaluation of TPM transcripts and proteins in developing striated chicken muscles indicate TPM4α is the major sarcomeric cardiac tropomyosin from early embryonic life to adulthood.

Authors:  Dipak K Dube; Syamalima Dube; Runa Shrestha; Lynn Abbott; Samender Randhawa; Vasundhara Muthu; Yingli Fan; Jushuo Wang; Jean M Sanger; Joseph W Sanger; Bernard J Poiesz
Journal:  Cytoskeleton (Hoboken)       Date:  2018-11-08

7.  Introducing a special edition of the Journal of Muscle Research and Cell Motility on tropomyosin: form and function.

Authors:  Steven Marston; Matthias Gautel
Journal:  J Muscle Res Cell Motil       Date:  2013-10-08       Impact factor: 2.698

8.  Cloning, Sequencing, and the Expression of the Elusive Sarcomeric TPM4α Isoform in Humans.

Authors:  Dipak K Dube; Syamalima Dube; Lynn Abbott; Ruham Alshiekh-Nasany; Charles Mitschow; Bernard J Poiesz
Journal:  Mol Biol Int       Date:  2016-09-15

9.  Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres.

Authors:  Michaela Yuen; Sandra T Cooper; Steve B Marston; Kristen J Nowak; Elyshia McNamara; Nancy Mokbel; Biljana Ilkovski; Gianina Ravenscroft; John Rendu; Josine M de Winter; Lars Klinge; Alan H Beggs; Kathryn N North; Coen A C Ottenheijm; Nigel F Clarke
Journal:  Hum Mol Genet       Date:  2015-08-24       Impact factor: 6.150

10.  Phosphorylation of Ser283 enhances the stiffness of the tropomyosin head-to-tail overlap domain.

Authors:  William Lehman; Greg Medlock; Xiaochuan Edward Li; Worawit Suphamungmee; An-Yue Tu; Anja Schmidtmann; Zoltán Ujfalusi; Stefan Fischer; Jeffrey R Moore; Michael A Geeves; Michael Regnier
Journal:  Arch Biochem Biophys       Date:  2015-02-26       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.